Expert Pitch
Rensselaer Polytechnic Institute (RPI)

How Should Remote Workers Cope with Isolation?

7-Apr-2020 1:10 PM EDT, by Rensselaer Polytechnic Institute (RPI)

With unprecedented numbers of workers quarantined and working from home, a chief complaint being voiced by many is how to deal with its isolating effects. What can be done to minimize the feelings of isolation and to maintain work relationships during this crisis?

Timothy Golden, a professor in the Lally School of Management at Rensselaer Polytechnic Institute, is a leading expert on remote work, telework, telecommuting, and virtual teams. With dozens of published research articles during more than 20 years of research in this field, his most recent article on telecommuting was just published in the Journal of Vocational Behavior.

“People working from home should be proactive if they want to avoid feeling isolated, so that they not only feel better but also maintain their work productivity. We know from research and experience that there are important activities that can be done to help solve remote work’s potential for isolation.”

Golden is available to discuss what steps workers can take to help avoid remote work’s isolating effects.




Filters close

Showing results

110 of 2538
Newswise: John Theurer Cancer Center Part of a New Study
in COVID-19 Patients Suggesting Activity of a Novel Agent BTK Inhibitor Acalabrutinib used as Anti-Cancer Drug in B-cell Malignancies
Released: 13-Jul-2020 3:45 PM EDT
John Theurer Cancer Center Part of a New Study in COVID-19 Patients Suggesting Activity of a Novel Agent BTK Inhibitor Acalabrutinib used as Anti-Cancer Drug in B-cell Malignancies
Hackensack Meridian Health

The mechanisms of action of acalabrutinib led to the hypothesis it might be effective in reducing the massive inflammatory response seen severe forms of COVID19. Indeed, it did provide clinical benefit in a small group of patients by reducing their inflammatory parameters and improving their oxygenation.

Newswise: National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Released: 13-Jul-2020 3:40 PM EDT
National Virtual Biotechnology Laboratory Unites DOE Labs Against COVID-19
Department of Energy, Office of Science

To focus its efforts against the COVID-19 pandemic, DOE is bringing the national laboratories together into the National Virtual Biotechnology Laboratory.

Newswise: Key Insights from Swedish Casino that Remained Open During COVID-19
Released: 13-Jul-2020 3:40 PM EDT
Key Insights from Swedish Casino that Remained Open During COVID-19
University of Nevada, Las Vegas (UNLV)

As casinos in Las Vegas enter the second month of reopening since the COVID-19 pandemic took hold, UNLV gaming researchers say they can draw upon insights from industry collaborators in Sweden, a country that took a more open approach to the crisis compared to other governments.

Released: 13-Jul-2020 3:05 PM EDT
Asymptomatic Transmission and Reinfection of COVID: Live Event for July 16, 2PM EDT
Newswise

Emerging data shows more risk of asymptomatic transmission and reinfection with COVID than previously thought. Experts will discuss these findings and what are the implications for managing the pandemic. Media are invited to attend and ask questions.

Released: 13-Jul-2020 2:40 PM EDT
Engineered llama antibodies neutralize COVID-19 virus
Rosalind Franklin Institute

Antibodies derived from llamas have been shown to neutralise the SARS-CoV-2 virus in lab tests, UK researchers announced today.

Released: 13-Jul-2020 1:25 PM EDT
1 in 3 young adults may face severe COVID-19
University of California, San Francisco (UCSF)

As the number of young adults infected with the coronavirus surges throughout the nation, a new study by researchers at UCSF Benioff Children's Hospitals indicates that youth may not shield people from serious disease.

Released: 13-Jul-2020 12:25 PM EDT
Scientists discover key element of strong antibody response to COVID-19
Scripps Research Institute

A team led by scientists at Scripps Research has discovered a common molecular feature found in many of the human antibodies that neutralize SARS-CoV-2, the coronavirus that causes COVID-19.

Released: 13-Jul-2020 11:15 AM EDT
UTHealth joins study of blood pressure medication’s effect on improving COVID-19 outcomes
University of Texas Health Science Center at Houston

An interventional therapy aimed at improving survival chances and reducing the need for critical care treatment due to COVID-19 is being investigated by physicians at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is underway at Memorial Hermann and Harris Health System’s Lyndon B. Johnson Hospital.

Newswise: Drug that calms ‘cytokine storm’ associated with 45% lower risk of dying among COVID-19 patients on ventilators
Released: 13-Jul-2020 7:25 AM EDT
Drug that calms ‘cytokine storm’ associated with 45% lower risk of dying among COVID-19 patients on ventilators
Michigan Medicine - University of Michigan

Critically ill COVID-19 patients who received a single dose of a drug that calms an overreacting immune system were 45% less likely to die overall, and more likely to be out of the hospital or off a ventilator one month after treatment, compared with those who didn’t receive the drug, according to a new observational study.


Showing results

110 of 2538

close
3.09616